IL-10 promotes neuronal survival following spinal cord injury

Experimental Neurology

Volumn 220, Issue 1, 2009, Pages 183-190

  Zhou, Zhigang ^a   Peng, Xiangmin ^a   Insolera, Ryan ^a   Fink, David J ^a   Mata, Marina ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Apoptosis; Cytokine; Gene therapy; Herpes simplex virus; Interleukin 10; Spinal cord injury

Indexed keywords

CASPASE 3; CYTOCHROME C; HERPES SIMPLEX VIRUS VECTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P50; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL NUCLEUS; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FEMALE; GENE EXPRESSION; GENE TRANSLOCATION; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOTOR PERFORMANCE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD HEMISECTION; SPINAL CORD INJURY; TISSUE HOMOGENATE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS REGULATORY PROTEINS; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GENE THERAPY; GENETIC VECTORS; INTERLEUKIN-10; NERVE DEGENERATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-10; SIGNAL TRANSDUCTION; SIMPLEXVIRUS; SPINAL CORD; SPINAL CORD INJURIES; TRANSFECTION; TREATMENT OUTCOME;

EID: 70349730234     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.08.018     Document Type: Article

References (22)

1. Abraham K.E., McMillen D., and Brewer K.L. The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse. Neuroscience 124 (2004) 945-952
2. Bachis A., Colangelo A.M., Vicini S., Doe P.P., De Bernardi M.A., Brooker G., and Mocchetti I. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J. Neurosci. 21 (2001) 3104-3112
3. Basso D.M., Beattie M.S., and Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12 (1995) 1-21
4. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., and Dietrich W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 16 (1999) 851-863
5. Boyd Z.S., Kriatchko A., Yang J., Agarwal N., Wax M.B., and Patil R.V. Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress. Invest. Ophthalmol. Vis. Sci. 44 (2003) 5206-5211
6. Brewer K.L., Bethea J.R., and Yezierski R.P. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp. Neurol. 159 (1999) 484-493
7. Citron B.A., Arnold P.M., Sebastian C., Qin F., Malladi S., Ameenuddin S., Landis M.E., and Festoff B.W. Rapid upregulation of caspase-3 in rat spinal cord after injury: mRNA, protein, and cellular localization correlates with apoptotic cell death. Exp. Neurol. 166 (2000) 213-226
8. Davies A.L., Hayes K.C., and Dekaban G.A. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch. Phys. Med. Rehabil. 88 (2007) 1384-1393
9. Dietrich W.D., Busto R., and Bethea J.R. Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp. Neurol. 158 (1999) 444-450
10. Dong H., Fazzaro A., Xiang C., Korsmeyer S.J., Jacquin M.F., and McDonald J.W. Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration. J. Neurosci. 23 (2003) 8682-8691
11. Grilli M., Barbieri I., Basudev H., Brusa R., Casati C., Lozza G., and Ongini E. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur. J. Neurosci. 12 (2000) 2265-2272
12. Howard M., O'Garra A., Ishida H., de Waal Malefyt R., and de Vries J. Biological properties of interleukin 10. J. Clin. Immunol. 12 (1992) 239-247
13. Jackson C.A., Messinger J., Peduzzi J.D., Ansardi D.C., and Morrow C.D. Enhanced functional recovery from spinal cord injury following intrathecal or intramuscular administration of poliovirus replicons encoding IL-10. Virology 336 (2005) 173-183
14. King V.R., Huang W.L., Dyall S.C., Curran O.E., Priestley J.V., and Michael-Titus A.T. omega-3 Fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 26 (2006) 4672-4680
15. Mitchell R.M., Freeman W.M., Randazzo W.T., Stephens H.E., Beard J.L., Simmons Z., and Connor J.R. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology 72 (2009) 14-19
16. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
17. Plunkett J.A., Yu C.G., Easton J.M., Bethea J.R., and Yezierski R.P. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp. Neurol. 168 (2001) 144-154
18. Sloane E., Ledeboer A., Seibert W., Coats B., van Strien M., Maier S.F., Johnson K.W., Chavez R., Watkins L.R., Leinwand L., Milligan E.D., and Van Dam A.M. Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental multiple sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain Behav. Immun. 23 (2009) 92-100
19. Springer J.E., Azbill R.D., and Knapp P.E. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat. Med. 5 (1999) 943-946
20. Takami T., Oudega M., Bethea J.R., Wood P.M., Kleitman N., and Bunge M.B. Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome. J. Neurotrauma 19 (2002) 653-666
21. Zhou Z., Peng X., Insolera S., Fink D.J., and Mata M. HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia. Gene. Ther. 15 (2008) 183-190
22. Zhou Z., Peng X., Hao R., Fink D.J., and Mata M. Interleukin-10 provides direct trophic support to neurons. J. Neurochem. 110 (2009) 1617-1627